Overweight improves long-term survival in Japanese patients with asthma

Author:

Yano Chiyo,Kawayama Tomotaka,Kinoshita Takashi,Tokunaga Yoshihisa,Sasaki Jun,Sakazaki Yuki,Matsuoka Masanobu,Imaoka Haruki,Nishiyama Mamoru,Matsunaga Kazuko,Furukawa Kyoji,Hoshino Tomoaki

Funder

Novartis

AstraZeneca

GlaxoSmithKline

Boehringer Ingelheim

Teijin Home Healthcare

Sanofi

Kyorin

MeijiSaika Pharma

GSK

Chugai Pharmaceutical

Publisher

Elsevier BV

Subject

General Medicine,Immunology and Allergy

Reference58 articles.

1. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

2. Global Asthma Network. The Global Asthma Report 2018. Available at: http://www.globalasthmanetwork.org/ [Accessed 1 April 2020].

3. Ministry of Health, Labour and Welfare, Japan. Available at: http://www.mhlw.go.jp/ [Accessed 10 November 2020].

4. Japanese guidelines for adult asthma 2017;Ichinose;Allergol Int,2017

5. The burden of severe asthma in France: a case-control study using a medical claims database;Bourdin;J Allergy Clin Immunol Pract,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3